Tumors ameliorate inflammatory and efficient tumor-specific cytotoxic T cell (CTL) responses by upregulating prostaglandin E2 (PGE2), a metabolic product derived from cyclooxygenase-2 (COX2) allowing immunosuppressive state [20]. Here, PTGS2 is linked to neoplasm.